These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 4378136
21. Adenovirus type 4 respiratory infections with a concurrent outbreak of coxsackievirus A21 among United States Army Basic Trainees, a retrospective viral etiology study using next-generation sequencing. Hang J, Vento TJ, Norby EA, Jarman RG, Keiser PB, Kuschner RA, Binn LN. J Med Virol; 2017 Aug; 89(8):1387-1394. PubMed ID: 28198541 [Abstract] [Full Text] [Related]
22. Recent experiences with live adenovirus vaccines in navy recruits. Rosenbaum MJ, Edwards EA, Hoeffler DF CAPT. Mil Med; 1975 Apr; 140(4):251-7. PubMed ID: 167324 [No Abstract] [Full Text] [Related]
23. A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits. Kuschner RA, Russell KL, Abuja M, Bauer KM, Faix DJ, Hait H, Henrick J, Jacobs M, Liss A, Lynch JA, Liu Q, Lyons AG, Malik M, Moon JE, Stubbs J, Sun W, Tang D, Towle AC, Walsh DS, Wilkerson D, Adenovirus Vaccine Efficacy Trial Consortium. Vaccine; 2013 Jun 19; 31(28):2963-71. PubMed ID: 23623865 [Abstract] [Full Text] [Related]
24. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Lyons A, Longfield J, Kuschner R, Straight T, Binn L, Seriwatana J, Reitstetter R, Froh IB, Craft D, McNabb K, Russell K, Metzgar D, Liss A, Sun X, Towle A, Sun W. Vaccine; 2008 Jun 02; 26(23):2890-8. PubMed ID: 18448211 [Abstract] [Full Text] [Related]
25. [Identification and typing of adenoviruses from pediatric patients with acute respiratory infections in Beijing from 2003 to 2008]. Deng J, Qian Y, Zhao LQ, Zhu RN, Wang F, Sun Y, Liao B, Huang RY, Yuan Y, Qu D, Ren XX. Zhonghua Er Ke Za Zhi; 2010 Oct 02; 48(10):739-43. PubMed ID: 21176480 [Abstract] [Full Text] [Related]
26. Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits. Hyer RN, Howell MR, Ryan MA, Gaydos JC. Am J Trop Med Hyg; 2000 May 02; 62(5):613-8. PubMed ID: 11289673 [Abstract] [Full Text] [Related]
27. Adenovirus pneumonia. McLean DM. Can Med Assoc J; 1973 Feb 17; 108(4):413 passim. PubMed ID: 4347081 [No Abstract] [Full Text] [Related]
28. Clinical picture and epidemiology of adenovirus infections (a review). Rubin BA. Acta Microbiol Hung; 1993 Feb 17; 40(4):303-23. PubMed ID: 7976207 [Abstract] [Full Text] [Related]
29. Further experience with Japanese encephalitis vaccine. Sanchez JL, Hoke CH, McCown J, DeFraites RF, Takafuji ET, Diniega BM, Pang LW. Lancet; 1990 Apr 21; 335(8695):972-3. PubMed ID: 1970043 [No Abstract] [Full Text] [Related]
30. [Human adenoviruses]. Brůcková M, Syrůcek L, Kunzová L. Cesk Epidemiol Mikrobiol Imunol; 1984 Nov 21; 33(6):362-74. PubMed ID: 6096030 [No Abstract] [Full Text] [Related]
31. Immunization with live type 4 adenovirus: determination of infectious virus dose and protective effect of enteric infection. Gutekunst RR, White RJ, Edmondson WP, Chanock RM. Am J Epidemiol; 1967 Sep 21; 86(2):341-9. PubMed ID: 4293744 [No Abstract] [Full Text] [Related]
32. Molecular characterization of adenoviruses among finnish military conscripts. Mölsä M, Hemmilä H, Rönkkö E, Virkki M, Nikkari S, Ziegler T. J Med Virol; 2016 Apr 21; 88(4):571-7. PubMed ID: 26308159 [Abstract] [Full Text] [Related]
33. Identification and Application of Neutralizing Epitopes of Human Adenovirus Type 55 Hexon Protein. Tian X, Ma Q, Jiang Z, Huang J, Liu Q, Lu X, Luo Q, Zhou R. Viruses; 2015 Oct 27; 7(10):5632-42. PubMed ID: 26516903 [Abstract] [Full Text] [Related]
34. Adenovirus-associated deaths in US military during postvaccination period, 1999-2010. Potter RN, Cantrell JA, Mallak CT, Gaydos JC. Emerg Infect Dis; 2012 Mar 27; 18(3):507-9. PubMed ID: 22377242 [Abstract] [Full Text] [Related]
35. DOSAGES OF VARIOUS TRIVALENT AND MONOVALENT ADENOVIRUS VACCINES IN THE PROPHLAXIS OF ACUTE RESPIRATORY ILLNESS. STILLE WT, HANTOVER MJ. Am J Hyg; 1964 Jul 27; 80():121-34. PubMed ID: 14192764 [No Abstract] [Full Text] [Related]
36. Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations. HILLEMAN MR. AMA Arch Intern Med; 1958 Jan 27; 101(1):47-53. PubMed ID: 13486965 [No Abstract] [Full Text] [Related]
37. Acute respiratory infections in civilian adults. I. Antibody response to polyvalent influenza--adenovirus inactivated vaccine. COX F, TIMM EA, QUINN EL, COLVILLE JM, McLEAN IW. Henry Ford Hosp Med Bull; 1962 Mar 27; 10():27-33. PubMed ID: 13881896 [No Abstract] [Full Text] [Related]
38. [Ecology of human adenoviruses]. Selivanov AA. Vestn Akad Med Nauk SSSR; 1983 Mar 27; (5):40-4. PubMed ID: 6306947 [No Abstract] [Full Text] [Related]
39. Vaccination with live type 4 adenovirus: evaluation of antibody response and protective efficacy. van der Veen J, Abarbanel MF, Oei KG. Antonie Van Leeuwenhoek; 1969 Mar 27; 35(2):239. PubMed ID: 4316421 [No Abstract] [Full Text] [Related]
40. Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. Takafuji ET, Gaydos JC, Allen RG, Top FH. J Infect Dis; 1979 Jul 27; 140(1):48-53. PubMed ID: 458200 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]